The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Plasma endothelin in chronic heart failure.
Abstract
BACKGROUND: Endothelins are recently characterized vasoconstrictor peptides. As chronic heart failure (CHF) is characterized by peripheral arteriolar and renal vasoconstriction, we have measured venous plasma endothelin-like immunoreactivity ("endothelin") in patients with this syndrome. METHODS AND RESULTS: Compared with age- and sex-matched healthy volunteers (mean +/- SEM plasma endothelin concentration 6.4 +/- 0.3 pmol/l, n = 16), patients with severe CHF had elevated peripheral venous endothelin concentrations (12.4 +/- 0.6 pmol/l, n = 47, p less than 0.01). Plasma endothelin did not increase with exercise in normal subjects or in patients. Plasma endothelin concentration (mean, 13.4 +/- 0.9 pmol/l) did not correlate with plasma atrial natriuretic factor concentration (mean, 88.9 +/- 11.9 pg/ml) in patients with CHF (n = 21). There was also no correlation between plasma endothelin and serum urea or between endothelin and serum creatinine in patients with CHF (n = 34). There was, however, significant renal extraction of endothelin (aorta, 11.1 +/- 0.8 pmol/l; renal vein, 8.8 +/- 0.6 pmol/ml; p = 0.02) in patients with CHF (n = 13). CONCLUSIONS: Evidence suggests that circulatory endothelin concentrations in the range 5-40 pmol/l are vasoactive. Consequently, the endothelin concentrations found in patients with CHF may be of pathophysiological significance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,729
de Nucci, G., Thomas, R., D'Orleans-Juste, P., Antunes, E., Walder, C., Warner, T. D., & Vane, J. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.24.9797 · Cited by 1,400
Increased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease?
Stewart, D. J., Levy, R. D., Cernacek, P., & Langleben, D. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-6-464 · Cited by 980
The Neurohumoral Axis in Congestive Heart Failure
FRANCIS, G. S., GOLDSMITH, S. R., LEVINE, T. B., OLIVARI, M. T., & COHN, J. N. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-3-370 · Cited by 600
Elevated plasma endothelin in patients with diabetes mellitus
Takahashi, K., Ghatei, M. A., Lam, H. C., O'Halloran, D. J., & Bloom, S. R. (1990) · Diabetologia · doi:10.1007/bf00403325 · Cited by 490
Integrated cardiac, renal, and endocrine actions of endothelin.
Miller, W. L., Redfield, M. M., & Burnett, J. C. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113876 · Cited by 473
Increased Plasma Endothelin Level in Patients with Essential Hypertension
(1990) · New England Journal of Medicine · doi:10.1056/nejm199001183220315 · Cited by 377
Alterations in vasomotor tone in congestive heart failure
Zelis, R., & Flaim, S. F. (1982) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(82)90012-3 · Cited by 363
Plasma immunoreactive endothelin in essential hypertension
Kohno, M., Yasunari, K., Murakawa, K.-I., Yokokawa, K., Horio, T., Fukui, T., & Takeda, T. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90527-k · Cited by 291
PLASMA ENDOTHELIN LEVELS IN PATIENTS WITH URAEMIA
Koyama, H., Nishzawa, Y., Morii, H., Tabata, T., Inoue, T., & Yamaji, T. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92631-7 · Cited by 286
Cited by
Cohn, J. N., Ferrari, R., & Sharpe, N. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00630-0 · Cited by 2,161
Piña, I. L., Apstein, C. S., Balady, G. J., Belardinelli, R., Chaitman, B. R., Duscha, B. D., Fletcher, B. J., Fleg, J. L., Myers, J. N., & Sullivan, M. J. (2003) · Circulation · doi:10.1161/01.cir.0000055013.92097.40 · Cited by 1,030
Endothelin System: The Double-Edged Sword in Health and Disease
Kedzierski, R. M., & Yanagisawa, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.851 · Cited by 745
Lüscher, T. F., & Barton, M. (2000) · Circulation · doi:10.1161/01.cir.102.19.2434 · Cited by 596
Krum, H., Viskoper, R. J., Lacourciere, Y., Budde, M., & Charlon, V. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803193381202 · Cited by 570
PATHOPHYSIOLOGY OF ENDOTHELIN IN THE CARDIOVASCULAR SYSTEM
Miyauchi, T., & Masaki, T. (1999) · Annual Review of Physiology · doi:10.1146/annurev.physiol.61.1.391 · Cited by 544
Exercise limitation in chronic heart failure: Central role of the periphery
Clark, A. L., Poole-Wilson, P. A., & Coats, A. J. S. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00323-3 · Cited by 524
Clozel, M., Breu, V., Burri, K., Cassal, J.-M., Fischli, W., Gray, G. A., Hirth, G., Löffier, B.-M., Müller, M., Neidhart, W., et al. (1993) · Nature · doi:10.1038/365759a0 · Cited by 518
Endothelin as a regulator of cardiovascular function in health and disease
Haynes, W. G., & Webb, D. J. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816080-00001 · Cited by 360
Mulder, P., Richard, V., Derumeaux, G., Hogie, M., Henry, J. P., Lallemand, F., Compagnon, P., Macé, B., Comoy, E., Letac, B., et al. (1997) · Circulation · doi:10.1161/01.cir.96.6.1976 · Cited by 360
McMurray, J. J. V., Teerlink, J. R., Cotter, G., Bourge, R. C., Cleland, J. G. F., Jondeau, G., Krum, H., Metra, M., O’Connor, C. M., Parker, J. D., et al. (2007) · JAMA · doi:10.1001/jama.298.17.2009 · Cited by 360
Self-citationAnand, I., McMurray, J., Cohn, J. N., Konstam, M. A., Notter, T., Quitzau, K., Ruschitzka, F., & Lüscher, T. F. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16723-8 · Cited by 347
Self-citationPacher, R., Stanek, B., Hülsmann, M., Koller-Strametz, J., Berger, R., Schuller, M., Hartter, E., Ogris, E., Frey, B., Heinz, G., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00520-x · Cited by 343
Pathophysiologic Targets in the Early Phase of Acute Heart Failure Syndromes
Gheorghiade, M., De Luca, L., Fonarow, G. C., Filippatos, G., Metra, M., & Francis, G. S. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.07.016 · Cited by 332
Endothelial dysfunction: Clinical implications
DREXLER, H. (1997) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(97)80030-8 · Cited by 293
Sakai, S., Miyauchi, T., Sakurai, T., Kasuya, Y., Ihara, M., Yamaguchi, I., Goto, K., & Sugishita, Y. (1996) · Circulation · doi:10.1161/01.cir.93.6.1214 · Cited by 286
Packer, M., McMurray, J., Massie, B. M., Caspi, A., Charlon, V., Cohen-Solal, A., Kiowski, W., Kostuk, W., Krum, H., Levine, B., et al. (2005) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2004.05.006 · Cited by 275
Self-citationBorovac, J. A., D'Amario, D., Bozic, J., & Glavas, D. (2020) · World Journal of Cardiology · doi:10.4330/wjc.v12.i8.373 · Cited by 195
Why does chronic heart failure cause breathlessness and fatigue?
Witte, K. K., & Clark, A. L. (2007) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2006.10.003 · Cited by 135
A Look Between the Cardiomyocytes: The Extracellular Matrix in Heart Failure
Miner, E. C., & Miller, W. L. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.1.71 · Cited by 86
Elevated endothelin-1 level is a risk factor for nonocclusive mesenteric ischemia
Groesdonk, H. V., Raffel, M., Speer, T., Bomberg, H., Schmied, W., Klingele, M., & Schäfers, H.-J. (2015) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.12.019 · Cited by 33
Metadata
- Authors
- McMurray, J. J., Ray, S. G., Abdullah, I., Dargie, H. J., & Morton, J. J.
- Venue
- Circulation
- Published
- 1992-04
- Volume
- 85
- Issue
- 4
- Pages
- 1374-1379
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2039767184
- Cited by
- 486
- References
- 17
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.